Zobrazeno 1 - 10
of 174
pro vyhledávání: '"A F, Sokolov"'
Autor:
M. A. Zelberg, N. Yu. Mironov, Kh. M. Dzaurova, Yu. A. Yuricheva, E. B. Maykov, P. S. Novikov, D. A. Gagloeva, M. A. Krimukova, S. F. Sokolov, S. P. Golitsyn
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 86-95 (2024)
Objective. Evaluate efficacy and safety of cavutilide (Refralon) for pharmacological cardioversion in patients with recurrent atrial fibrillation and flutter (AF/AFL), in 90days blanking period of catheter ablation.Materials and methods. included 56
Externí odkaz:
https://doaj.org/article/22ac86e42166436abe584631dc932ef7
Autor:
Victor F. Sokolov
Publikováno v:
Mathematics, Vol 12, Iss 2, p 197 (2024)
This paper addresses a problem of optimal error quantification in the framework of robust control theory in the 𝓁1 setup. The upper bounds of biased external disturbance and the gains of coprime factor perturbations in a discrete-time linear time
Externí odkaz:
https://doaj.org/article/8fcd6c6ba0244cdfa879a1fb79ffb17b
Autor:
Maria M. Beliaeva, Khava M. Dzaurova, Yulia A. Yuricheva, Peter S. Novikov, Nikolay Yu. Mironov, Gennady S. Tarasovskiy, Maksim A. Zelberg, Sergey F. Sokolov, Sergey P. Golitsyn
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 12, p 487 (2023)
This work aimed to study the efficacy and safety of the class III antiarrhythmic agent cavutilide (Niferidil, Refralon) for pharmacological cardioversion in patients with paroxysmal and persistent atrial fibrillation (AF) and heart failure (HF). Meth
Externí odkaz:
https://doaj.org/article/59e0f27aa6aa43e3b39c3228380d54df
Autor:
D. A. Gagloeva, Kh. M. Dzaurova, M. A. Zelberg, N. Yu. Mironov, Yu. A. Yuricheva, S. F. Sokolov, M. A. Krymukova, A. I. Salpagarova, L. O. Dulaev, D. V. Pevzner, S. P. Golitsyn
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 4 (2023)
Aim. To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibrillation and flutter (AF/AFL).Material and methods. Fifty five patients (mean age, 65±11 years) with paroxy
Externí odkaz:
https://doaj.org/article/9421170c3fc74df083e12f23e2bc4e63
Autor:
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 668-673 (2021)
Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research cent
Externí odkaz:
https://doaj.org/article/fda3bc3bcec0409e89ef6af250af93a3
Autor:
Khava M. Dzaurova, Nikolay Yu. Mironov, Yuliia A. Yuricheva, Vladislav V. Vlodzyanovsky, Nataliia A. Mironova, Lada Yu. Laiovich, Tatiana A. Malkina, Liudmila V. Zinchenko, Sergei F. Sokolov, Sergey P. Golitsyn
Publikováno v:
Терапевтический архив, Vol 93, Iss 9, Pp 1052-1057 (2021)
Aim. Evaluation of the efficacy and safety of the modified refralon administration protocol for the relief of paroxysmal atrial fibrillation (AF). Materials and methods. The study included 39 patients (19 men, mean age 6312.8 years). All patients,
Externí odkaz:
https://doaj.org/article/6b4b489736104a66bec087582d7c3b89
Autor:
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 2, Pp 193-199 (2021)
Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research cent
Externí odkaz:
https://doaj.org/article/0f377f87549f4a628c7889891fa7039f
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 4, Pp 350-360 (2019)
The possibility to identify potentially life-threatening ventricular arrhythmias by analysis of standard electrocardiography (ECG) parameters without the use of sophisticated and expensive diagnostic techniques, such as electrophysiological heart stu
Externí odkaz:
https://doaj.org/article/fe453c1a7efe46d39d4b0ce83fd4de4f
Publikováno v:
Терапевтический архив, Vol 91, Iss 4, Pp 83-89 (2019)
Aim. To evaluate standard 12-lead ECG indices for the differential diagnosis of wide QRS tachycardias with right bundle branch block (RBBB) pattern. Materials and methods. Study analyses the 244 ECG indices in 111 patients (79 males and 32 females, a
Externí odkaz:
https://doaj.org/article/dea4f93ef3b44589a8aff943c3e83f2f
Autor:
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 6, Pp 826-830 (2019)
Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current cardioversion (DCC) in patients with persistent atrial fibrillation (AF). Material and methods. 60 patients with persistent AF were randomized to groups of DCC (
Externí odkaz:
https://doaj.org/article/f47249aaf92d44f9aa129d5064c2d1e0